Inflammatory bowel disease drug trial starts by region
3 regions, 2020 to 2025
94
Global, 2025
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 95. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025).
0
20
40
60
80
100
2020
2021
2022
2023
2024
2025
Global
United States
China
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 95. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025).
0
30
60
90
120
2020
2021
2022
2023
2024
2025
Global
United States
China
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 12 to 95. Latest values: Global 94 (2025); United States 37 (2025); China 31 (2025).
0
30
60
90
120
2020
2021
2022
2023
2024
2025
Global
United States
China
View the underlying data
Inflammatory bowel disease drug trial starts by region: 3 regions, 2020 to 2025
Region
Period
Type
Value
Global
2025
Actual
94
Global
2024
Actual
87
Global
2023
Actual
95
Global
2022
Actual
88
Global
2021
Actual
88
Global
2020
Actual
73
United States
2025
Actual
37
United States
2024
Actual
35
United States
2023
Actual
36
United States
2022
Actual
35
United States
2021
Actual
42
United States
2020
Actual
32
China
2025
Actual
31
China
2024
Actual
22
China
2023
Actual
16
China
2022
Actual
18
China
2021
Actual
12
China
2020
Actual
12
Chart:
StatOrigin
· Source: ClinicalTrials.gov ·
statorigin.org
CC BY 4.0